| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/11/2015 | CN104337767A 一种pH敏感性药物载体胶束的制备方法 A method for preparing a pH-sensitive micelle drug carriers |
| 02/11/2015 | CN104337761A 氟维司群药物组合物 Fulvestrant pharmaceutical composition |
| 02/11/2015 | CN104337760A 一种二盐酸组胺注射液及其制备方法 One kind of histamine dihydrochloride injection and its preparation method |
| 02/11/2015 | CN103621742B 一种蔷薇花茶、其制备方法和用途 The rose tea, their preparation and use |
| 02/11/2015 | CN103446083B 海兔素在制备治疗胶质瘤的药物中的用途 Aplysia hormone use in the manufacture of a medicament for the treatment of glioma |
| 02/11/2015 | CN103446055B 三羟基异黄酮脂质纳米体的制备方法 Preparation trihydroxyisoflavone body lipid nano |
| 02/11/2015 | CN103417620B 溪黄草提取物作为stat3信号特异性抑制剂在制备抗肿瘤药物中的应用 Xihuangcao extract as stat3 signal inhibitor used in the preparation of anticancer drugs |
| 02/11/2015 | CN103408652B 一种新型抗HBV内源蛋白HNF1α及其应用 A source of protein in the new anti-HBV HNF1α its application |
| 02/11/2015 | CN103381232B 一种抗癌中药及其制备方法 An anti-cancer medicine and its preparation method |
| 02/11/2015 | CN103374066B αB-超家族芋螺毒素肽、其药物组合物及用途 αB- superfamily conotoxin peptides, pharmaceutical compositions and uses |
| 02/11/2015 | CN103342687B 一类具有酪氨酸酶抑制活性的化合物及其制备与应用 A class of compounds has tyrosinase inhibitory activity and its preparation and application |
| 02/11/2015 | CN103301366B 一种治疗癌症的药物以及制备方法 A cure for cancer and preparation methods |
| 02/11/2015 | CN103275227B Axl抗体 Axl antibody |
| 02/11/2015 | CN103263675B 一种聚ε-己内酯负载的抗肿瘤前药及其制备方法 An antitumor prodrugs and preparation method ε- caprolactone load poly |
| 02/11/2015 | CN103223165B 肿瘤细胞所导致的免疫抑制的解除剂及使用该解除剂的抗肿瘤剂 Immune suppression caused by tumor cells releasing agent using the releasing agent is an antitumor agent |
| 02/11/2015 | CN103193820B 一种氮芥磷脂化合物及其制备方法 A phospholipid compounds and methods of mustard |
| 02/11/2015 | CN103183722B 一种乙二醛酶i抑制剂及其制备方法和医药用途 One kind glyoxylase i inhibitor and its preparation method and medicinal uses |
| 02/11/2015 | CN102961417B 具有抗肺癌作用的中药多组分微乳组合物、其制备方法及其在制备口服抗肺癌药物中的应用 Multi-component microemulsion composition of traditional Chinese medicine with anti-cancer effects, their preparation and their use in the preparation of oral anti-cancer medicine |
| 02/11/2015 | CN102827282B 人源抗Trop-2基因工程抗体IgG及其应用 Human anti-Trop-2 antibody IgG and its application of genetic engineering |
| 02/11/2015 | CN102772696B 硒环肽·脂肪酸合剂及其制备方法 Selenium cyclic peptide mixture of fatty acids and its preparation method |
| 02/11/2015 | CN102772365B 4-(4-(3-三氟甲基)苯甲酰胺基苯氧基)-2-(甲基氨甲酰基)吡啶纳米混悬剂及其制法和应用 4- (4- (3-trifluoromethyl) benzamido phenoxy) -2- (methylcarbamoyl) pyridin nanosuspension preparation method and application |
| 02/11/2015 | CN102558300B 能拮抗促肾上腺皮质激素释放因子受体1的多肽及其用途 Antagonize corticotropin releasing factor receptor polypeptides and uses 1 |
| 02/11/2015 | CN102552300B 莫能菌素作为stat3信号特异性抑制剂的应用 Monensin stat3 signal as an application specific inhibitors |
| 02/11/2015 | CN102532159B 动点马达蛋白CENP-E小分子抑制剂Syntelin Fixed point motor protein CENP-E small molecule inhibitors Syntelin |
| 02/11/2015 | CN102343089B 一种治疗乳癌的医药组成物 A method of treating breast cancer in a pharmaceutical composition |
| 02/11/2015 | CN102317291B 稠合嘧啶 Fused pyrimidine |
| 02/11/2015 | CN101998853B 作为amp-活化的蛋白激酶(ampk)激活剂的噻吩并吡啶酮衍生物 As amp- activated protein kinase thiophene (ampk) activator and pyridone derivative |
| 02/11/2015 | CN101939446B 人类卵巢癌中的微小rna特征 Human ovarian cancer characterized by small rna |
| 02/11/2015 | CN101798355B 一种综合分离提取茶多糖、茶氨酸、茶多酚和咖啡因的方法 An integrated method for separation and extraction of tea polysaccharide, theanine, polyphenols and caffeine |
| 02/11/2015 | CN101080223B 辛二酰苯胺异羟肟酸制剂及其制备方法 Suberoylanilide hydroxamic acid and its preparation method |
| 02/10/2015 | US8952019 Methods of using selective chemotherapeutic agents for targeting tumor cells |
| 02/10/2015 | US8951972 FGFR1 extracellular domain combination therapies for lung cancer |
| 02/10/2015 | US8951971 Lymphatic zip codes in tumors and pre-malignant lesions |
| 02/10/2015 | US8951772 Adenoviruses, nucleic acids coding therefor, and use thereof |
| 02/10/2015 | US8951737 Treatment and diagnosis of cancer |
| 02/10/2015 | CA2700905C C7-substituted camptothecin analogs |
| 02/10/2015 | CA2653662C Spirocyclic nitriles as protease inhibitors |
| 02/10/2015 | CA2648895C Camptothecin-analog with a novel, "flipped" lactone-stable, e-ring and methods for making and using same |
| 02/10/2015 | CA2632437C 1,2,4-triazol-1-yl bisphenyl derivatives for use in the treatment of endocrine-dependent tumours |
| 02/10/2015 | CA2573262C Conjugates of a gm-csf moiety and a polymer |
| 02/10/2015 | CA2537473C Cytokine involved in epithelial-mesenchymal transition |
| 02/05/2015 | WO2015017863A1 Methods for the detection and treatment of leukemias that are responsive to dot1l inhibition |
| 02/05/2015 | WO2015017822A1 Antibodies or fusion proteins multimerized via homomultimerizing peptide |
| 02/05/2015 | WO2015017812A1 Methods for the treatment of solid tumors |
| 02/05/2015 | WO2015017600A1 Afucosylated anti-fgfr2iiib antibodies |
| 02/05/2015 | WO2015017552A1 Antibody drug conjugates (adc) that bind to cd37 proteins |
| 02/05/2015 | WO2015017466A1 Formulation of syk inhibitors |
| 02/05/2015 | WO2015017034A1 Methods of treating a cancer through targeted disruption of alpha connexin 43-zonula occludens-1 (zo-1) interaction |
| 02/05/2015 | WO2015016559A1 Anti-egfr antibody and anti-c-met/anti-egfr bispecific antibodies comprising the same |
| 02/05/2015 | WO2015016475A1 Pharmaceutical use of c-yes for differentiation therapy of cancer stem cells |
| 02/05/2015 | WO2015016295A1 Pharmaceutical preparation comprising aminopyrazole derivative |
| 02/05/2015 | WO2015016195A1 Wnt SIGNALING INHIBITOR |
| 02/05/2015 | WO2015015989A1 Agent for alleviating side effects in cancer chemotherapy |
| 02/05/2015 | WO2015015496A1 Sphingolipid-polyalkylamine-oligonucleotide compounds |
| 02/05/2015 | WO2015015420A1 Novel derivatives of a 3,4-dihydroisoquinoline-3-carboxylic acid having anti-cancer properties, a method for their synthesis, pharmaceutical compositions comprising said derivatives, and their use |
| 02/05/2015 | WO2015015301A2 Cancer therapy with silver nanoparticles |
| 02/05/2015 | WO2015015013A1 Combinations of a btk inhibitor and fluorouracil for treating cancers |
| 02/05/2015 | WO2015014998A1 Pharmaceutical formulation containing thienotriazolodiazepine compounds |
| 02/05/2015 | WO2015014879A1 Use of anti-muc1 maytansinoid immunoconjugate antibody for the treatment of solid tumors |
| 02/05/2015 | WO2015014851A1 Hydroxyalkyl starch for the treatment of hematological neoplasms |
| 02/05/2015 | WO2015014730A1 Polysaccharide for use in preventing metastasis formation and/or relapse |
| 02/05/2015 | WO2015014659A1 Anti-claudin 1 antibodies and uses thereof |
| 02/05/2015 | WO2015014657A1 Anti-claudin 1 antibodies for use in the treatment of colorectal cancer |
| 02/05/2015 | WO2015014442A1 Oxoquinazolinyl-butanamide derivatives |
| 02/05/2015 | WO2015014329A1 Pharmaceutical composition comprising monensin for treating of diseases associated with deregulated wnt signaling pathway |
| 02/05/2015 | WO2015014315A1 Inhibitor crystalline form and preparation method and use thereof |
| 02/05/2015 | WO2015014284A1 Method for treating breast cancer |
| 02/05/2015 | WO2015014283A1 Protein tyrosine kinase inhibitor and application thereof |
| 02/05/2015 | WO2015013932A1 Nutritional composition for inhibiting growth of tumor |
| 02/05/2015 | WO2014071378A9 Substituted indol-5-ol derivatives and their therapeutical applications |
| 02/05/2015 | US20150037442 Composition to Enhance the Bioavailability of Curcumin |
| 02/05/2015 | US20150037400 Cytotoxic agents |
| 02/05/2015 | US20150037287 Method of Treating a Malignancy in a Subject and a Pharmaceutical Composition for Use in Same |
| 02/05/2015 | DE102013013029A1 Lobbyist-Zellschutz PNI (Psychoneuroimmunium) Lobbyist cell protection PNI (Psychoneuroimmunium) |
| 02/04/2015 | EP2832857A1 Anti-siglec15 antibody with modified cdr |
| 02/04/2015 | EP2832856A1 Anti-lamp5 antibody and utilization thereof |
| 02/04/2015 | EP2832855A1 Novel anti-siglec15 antibody |
| 02/04/2015 | EP2832748A1 Anti-EGFR antibody and Anti-C-Met/Anti-EGFR bispecific antibodies comprising the same |
| 02/04/2015 | EP2832746A1 Anti-Ang2 antibody |
| 02/04/2015 | EP2832740A1 SALT OF 1-(2-DEOXY-2-FLUORO-4-THIO-beta-D-ARABINOFURANOSYL)CYTOSINE |
| 02/04/2015 | EP2832373A1 Method to block site-specifically chemokine-related inflammatory processes in vascular diseases and metastasis |
| 02/04/2015 | EP2832367A1 Agent for preventing or treating giant cell tumor or chondrosarcoma arising in bone/soft tissue |
| 02/04/2015 | EP2832366A1 Pharmaceutical composition for treatment and/or prevention of gall bladder cancer |
| 02/04/2015 | EP2832365A1 Pharmaceutical composition for treatment and/or prevention of liver cancer |
| 02/04/2015 | EP2832363A1 Epitopes of epidermal growth factor receptor surface antigen and use thereof |
| 02/04/2015 | EP2832360A1 Polysaccharide for use in preventing metastasis formation and/or relapse |
| 02/04/2015 | EP2832358A1 Pharmaceutical kit for use in the treatment of colon and colorectal cancer |
| 02/04/2015 | EP2832355A1 Anticancer agent |
| 02/04/2015 | EP2832349A1 Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method thereof |
| 02/04/2015 | EP2832348A1 Method for dissolving flavonoid compound, carbon glycoside compound, or stilbene compound and method for preparing injection or powder for injection |
| 02/04/2015 | EP2831592A1 Breast cancer assay |
| 02/04/2015 | EP2831118A1 Anti-lgr5 antibodies and immunoconjugates |
| 02/04/2015 | EP2831111A1 Ang2-binding molecules |
| 02/04/2015 | EP2831103A1 Anti-tumor properties of dickkopf 3b |
| 02/04/2015 | EP2831093A1 Egfl7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis |
| 02/04/2015 | EP2831080A1 Lactam kinase inhibitors |
| 02/04/2015 | EP2831079A1 Bicyclic heterocyclic derivatives as mnk1 and mnk2 modulators and uses thereof |
| 02/04/2015 | EP2831073A2 Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b]pyridine compounds as modulators of c-met protein kinases |
| 02/04/2015 | EP2831067A1 Small molecule inhibitors of mcl-1 and uses thereof |
| 02/04/2015 | EP2831063A1 Schweinfurthin analogues |